ATLAS VENTURE ASSOCIATES X, L.P.'s Net Worth
$45.9 Million
Who is ATLAS VENTURE ASSOCIATES X, L.P.?
ATLAS VENTURE ASSOCIATES X, L.P. has an estimated net worth of $45.9 Million. This is based on reported shares across multiple companies, which include Day One Biopharmaceuticals Holding Co LLC, Generation Bio Co., Replimune Group, Inc., Ikena Oncology, Inc., Kymera Therapeutics, Inc., Magenta Therapeutics, Inc., Disc Medicine, Inc., AVROBIO, Inc., and Homology Medicines, Inc..
SEC CIK
ATLAS VENTURE ASSOCIATES X, L.P.'s CIK is 0001742766
Past Insider Trading and Trends
2021 was ATLAS VENTURE ASSOCIATES X, L.P.'s most active year for disposing of shares, totalling 29 transactions. ATLAS VENTURE ASSOCIATES X, L.P.'s most active month to dispose stocks was the month of March. In 2021 ATLAS VENTURE ASSOCIATES X, L.P. cashed out on 1,170,632 shares for a total of $45,947,931.72, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Generation Bio Co. (GBIO) Snapshot price: $2.18
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -99.26% | -81.09K |
$25.40 | -$2,059,519.16 | 608 |
Scheduled
|
Sep 27 - Sep 29
| ||
Form 4
| -62.30% | -135.00K |
$26.02 | -$3,511,992.53 | 81.7K |
Scheduled
|
Sep 22 - Sep 24
| ||
Form 4
| -98.08% | -31.01K |
$25.86 | -$801,618.16 | 608 |
Scheduled
|
Jun 24
| ||
Form 4
| -85.41% | -185.08K |
$25.05 | -$4,635,967.02 | 31.62K |
Scheduled
|
Jun 21 - Jun 23
| ||
Form 4
| -100.00% | -140.68K |
$25.92 | -$3,646,968.15 |
0
|
Scheduled
|
Apr 12 - Apr 14
| ||
Form 4
| -47.46% | -127.09K |
$28.20 | -$3,583,860.22 | 140.68K |
Scheduled
|
Apr 7 - Apr 9
| ||
Form 4
| +387.54% | 10.04M |
—
|
—
| 12.63M |
Jun 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Replimune Group, Inc. (REPL) Snapshot price: $10.88
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.45M |
—
|
—
| 4.45M |
Jul 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Ikena Oncology, Inc. (IKNA) Snapshot price: $1.77
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +2,809.29% | 4.75M |
—
|
—
| 4.92M |
Mar 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Kymera Therapeutics, Inc. (KYMR) Snapshot price: $45.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.03% | -353.36K |
$42.20 | -$14,912,376.40 | 5.5M |
Scheduled
|
Mar 11 - Mar 13
| ||
Form 4
| -2.11% | -126.47K |
$30.22 | -$3,821,738.64 | 5.86M |
Scheduled
|
Jan 11 - Jan 12
| ||
Form 4
| -6.00% | -382.24K |
$31.36 | -$11,985,953.69 | 5.98M |
Scheduled
|
Dec 14 - Dec 15
| ||
Form 4
| -3.34% | -220.02K |
$30.01 | -$6,602,952.38 | 6.37M |
Scheduled
|
Nov 2 - Nov 3
| ||
Form 4
| -4.20% | -288.70K |
$30.26 | -$8,735,143.37 | 6.59M |
Scheduled
|
Oct 28 - Nov 1
| ||
Form 4
| -100.00% | -242.13K |
$61.00 | -$14,770,113.00 |
0
|
Aug 11
| |||
Form 4
| -100.00% | -229.35K |
$56.50 | -$12,958,275.00 |
0
|
Mar 12
| |||
Form 4
| +1,104.37% | 8.31M |
—
|
—
| 9.06M |
Aug 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Magenta Therapeutics, Inc. (DNTH) Snapshot price: $26.62
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -15.00% | -726.50K |
$17.86 | -$254,415.70 | 4.12M |
Mar 20
| |||
Form 4
| +4,906.38% | 4.75M |
—
|
—
| 4.84M |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |